Session Time: 12:00pm-1:30pm
Location: Exhibit Hall located in Hall B, Level 2
Objective: We aim to inform physicians on the value of physiotherapy (PT) for people with Parkinson’s disease (PwP) and on opportunities to optimize referral to and communication with PTs. Recommendations are based on the part of the European Physiotherapy Guideline for Parkinson’s disease (PD) for physicians.
Background: PD is a complex condition, requiring involvement of health professionals from various disciplines. The evidence-base for high quality, non-pharmacological care for PwP is growing and its implementation is gaining momentum. The Guideline supports PTs in making patient-centered, evidence-based decisions. Specific information for physicians and for PwP is included, to improve the implementation of good PT care.
Methods: The Guideline was developed in a joint collaboration of national PT associations from 19 European countries. Opinion leaders, PT’s, physicians and patients were informed and involved in the developmental process. The Guideline was based on a systematic analysis of the literature, according to international standards (AGREE and GRADE).
Results: Referral to PT should be considered in the early stage of disease, at the onset of activity limitations and at hospital admission. Early referral is desired, because difficulties in daily activities may already be present. PTs can support PwP in self-management by education about maintaining sufficient physical activity levels. Also in later stages there is consistent evidence supporting PT referral, e.g. to improve gait and prevent falls. At hospital admission PTs can provide education and exercise for prevention of pressure sores and a decrease of physical capacity. During and upon completion of a treatment period, the PT will communicate with the referring neurologist about the treatment goal (determined together with the patient), treatment plan and (expected) effect, supported by validated assessment tools. The referring physician has an important role in guiding PwP to an expert PT, as nearly all PwP will follow their physician’s advice. Expert PT’s are fully-informed regarding the evidence on PT-specific interventions and treat a higher than average patient volume, which is essential for good PD care.
Conclusions: PwP can benefit from PT treatment in all disease stages and referral to PT should be considered even in the early stages. The Guideline, including the physicians and PwP parts, is openly available at www.parkinsonnet.info/euguideline.
To cite this abstract in AMA style:D.L.M. Radder, M.J. Faber, N.M. de Vries, B.R. Bloem, S.H.J. Keus. European physiotherapy guideline for Parkinson’s disease: Information for neurologists [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/european-physiotherapy-guideline-for-parkinsons-disease-information-for-neurologists/. Accessed March 2, 2024.
« Back to 2016 International Congress
MDS Abstracts - https://www.mdsabstracts.org/abstract/european-physiotherapy-guideline-for-parkinsons-disease-information-for-neurologists/